253 related articles for article (PubMed ID: 35634299)
1. High-Frequency Notable HBV Mutations Identified in Blood Donors With Occult Hepatitis B Infection From Heyuan City of Southern China.
Ye X; Liu L; Chen L; Nie X; Huang L; Ye D; Zeng J; Li T; Li B; Xu M; Chen L
Front Immunol; 2022; 13():754383. PubMed ID: 35634299
[TBL] [Abstract][Full Text] [Related]
2. High Frequency Occult Hepatitis B Virus Infection Detected in Non-Resolved Donations Suggests the Requirement of Anti-HBc Test in Blood Donors in Southern China.
Ye X; Zhao Y; Li R; Li T; Zheng X; Xiong W; Zeng J; Xu M; Chen L
Front Immunol; 2021; 12():699217. PubMed ID: 34394093
[TBL] [Abstract][Full Text] [Related]
3. Molecular characteristics of HBV infection among blood donors tested HBsAg reactive in a single ELISA test in southern China.
Ye X; Li T; Li R; Liu H; Zhao J; Zeng J
BMC Infect Dis; 2021 Jan; 21(1):83. PubMed ID: 33468062
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of hepatitis B virus infections in blood donors born before and after the implementation of universal HBV vaccination in southern China.
Ye X; Li T; Li Y; Zeng J; Li R; Xu X; Guan X; Li L
Transfus Med; 2023 Feb; 33(1):81-89. PubMed ID: 36815535
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
González R; Torres P; Castro E; Barbolla L; Candotti D; Koppelman M; Zaaijer HL; Lelie N; Allain JP; Echevarría JM
Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332
[TBL] [Abstract][Full Text] [Related]
6. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
van de Laar TJ; Hogema BM; Molenaar-de Backer MW; Marijt-van der Kreek T; Zaaijer HL
Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
[TBL] [Abstract][Full Text] [Related]
7. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
Kuhns MC; Holzmayer V; Anderson M; McNamara AL; Sauleda S; Mbanya D; Duong PT; Dung NTT; Cloherty GA
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696483
[TBL] [Abstract][Full Text] [Related]
8. Characterization of occult hepatitis B virus infection from blood donors in China.
Zheng X; Ye X; Zhang L; Wang W; Shuai L; Wang A; Zeng J; Candotti D; Allain JP; Li C
J Clin Microbiol; 2011 May; 49(5):1730-7. PubMed ID: 21411575
[TBL] [Abstract][Full Text] [Related]
9. Challenges in hepatitis B detection among blood donors.
Allain JP; Cox L
Curr Opin Hematol; 2011 Nov; 18(6):461-6. PubMed ID: 21912252
[TBL] [Abstract][Full Text] [Related]
10. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
Kiely P; Margaritis AR; Seed CR; Yang H;
Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of hepatitis B virus infections in blood donors in southern China that are surface antigen positive but nucleic acid testing negative.
Ye X; Li T; Zhang R; Liu H; Zeng J; Hong W; Lu L; Zhu W; Li S; Xu M; Wu S; Chen L
Transfusion; 2020 Jul; 60(7):1476-1482. PubMed ID: 32358842
[TBL] [Abstract][Full Text] [Related]
13. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
[TBL] [Abstract][Full Text] [Related]
14. The characteristics of hepatitis B surface antigen (HBsAg)-negative hepatitis B virus (HBV) infection in Chinese blood donors: a follow-up study of donors tested negative for HBsAg and reactive for simultaneous nucleic acid testing of HBV, hepatitis C virus, and human immunodeficiency virus.
Guo Z; Fu P; Yin Y; Wang F; Yin Y; Wang J; Liu Y
Transfusion; 2017 Mar; 57(3pt2):832-840. PubMed ID: 28164313
[TBL] [Abstract][Full Text] [Related]
15. Molecular characteristics of occult hepatitis B virus from blood donors in southeast China.
Yuan Q; Ou SH; Chen CR; Ge SX; Pei B; Chen QR; Yan Q; Lin YC; Ni HY; Huang CH; Yeo AE; Shih JW; Zhang J; Xia NS
J Clin Microbiol; 2010 Feb; 48(2):357-62. PubMed ID: 19940057
[TBL] [Abstract][Full Text] [Related]
16. Occult and active hepatitis B virus detection in donated blood in São Paulo, Brazil.
Nishiya AS; Levi JE; de Almeida-Neto C; Witkin SS; Ferreira SC; Bassit L; Sabino EC; Di-Lorenzo-Oliveira C; Salles NA; Coutinho AS; Bellesa MA; Rocha V; Mendrone-Jr A
Transfusion; 2021 May; 61(5):1495-1504. PubMed ID: 33687074
[TBL] [Abstract][Full Text] [Related]
17. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains.
Candotti D; Grabarczyk P; Ghiazza P; Roig R; Casamitjana N; Iudicone P; Schmidt M; Bird A; Crookes R; Brojer E; Miceli M; Amiri A; Li C; Allain JP
J Hepatol; 2008 Oct; 49(4):537-47. PubMed ID: 18602718
[TBL] [Abstract][Full Text] [Related]
18. Characteristic of HBV nucleic acid amplification testing yields from blood donors in China.
Wu D; Wang X; Feng F; Wang D; Hu Y; Yu Y; Huang J; Wang M; Dong J; Wu Y; Zhu H; Zhu F
BMC Infect Dis; 2021 Jul; 21(1):714. PubMed ID: 34330225
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].
Boumbaly S; Balde TAL; Semenov AV; Ostankova YV; Serikova EN; Naidenova EV; Valutite DE; Shchemelev AN; Zueva EB; Esaulenko EV; Totolian AA
Vopr Virusol; 2022 Mar; 67(1):59-68. PubMed ID: 35293189
[TBL] [Abstract][Full Text] [Related]
20. A mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections.
Vermeulen M; van Drimmelen H; Coleman C; Mitchel J; Reddy R; Lelie N
Transfusion; 2014 Oct; 54(10):2496-504. PubMed ID: 24749834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
